Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced ...
CEO Evan Gappelberg Acquires Securities of Nextech3D.ai Corp.
TORONTO, ON / ACCESS Newswire / February 7, 2025 / Evan Gappelberg ("Acquiror") announces that he has acquired ownership and ...
Rareview Capital and Tuttle Capital Management Launch 2X Bull Cryptocurrency & Precious ...
Modern Digital Assets + Timeless Metals, All at 2X LeverageLas Vegas, Nevada--(Newsfile Corp. - February 7, 2025) - ...